Molecular interactions of rifabutin with membrane under acidic conditions

被引:4
作者
Pinheiro, Marina [1 ]
Silva, Ana Sofia [1 ]
Reis, Salette [1 ]
机构
[1] Univ Porto, REQUIMTE, Dept Ciencias Quim, Fac Farm, P-4050313 Oporto, Portugal
关键词
Membrane biophysical studies; Drug-membrane studies; Membrane models; Rifabutin; Tuberculosis; HELICOBACTER-PYLORI INFECTION; BIOPHYSICAL PROPERTIES; DPPC LIPOSOMES; PHARMACOKINETICS; TUBERCULOSIS; RIFAMPIN;
D O I
10.1016/j.ijpharm.2014.12.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work focuses on the interaction of the anti-tuberculosis (anti-TB) drug, rifabutin (RFB) with cell membrane models formed by 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC). The experiments were performed under acidic conditions (i.e., pH 5.0) taking into account the pH conditions that RFB may find in the course of its in vivo pharmacological activity. The partition of the drug to the membrane was quantified through the partition coefficient (K-p). Fluorescence quenching studies were performed to predict the drug's location across the cell membrane model. The effect of RFB on the biophysical parameters of the cell membrane model was studied by steady-state anisotropy and small-angle X-ray scattering (SAXS). The overall results point to a marked interaction of RFB with cell membranes under acidic pH, which may be related with its pharmacological effects. The in vivo success of RFB may be associated with the drug's disordering effect of the membranes under acidic pH values environments, and consequently drug accumulation in the gastric infected tissues and inside phagolysosomes. On the other hand, the present study allowed establishing important correlations with the gastrointestinal side effects caused by RFB. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 32 条
[11]   Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis [J].
Jamieson, F. B. ;
Guthrie, J. L. ;
Neemuchwala, A. ;
Lastovetska, O. ;
Melano, R. G. ;
Mehaffy, C. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (06) :2157-2162
[12]   Location of diphenylhexatriene (DPH) and its derivatives within membranes: Comparison of different fluorescence quenching analyses of membrane depth (vol 37, pg 8180, 1998) [J].
Kaiser, RD ;
London, E .
BIOCHEMISTRY, 1999, 38 (08) :2610-2610
[13]  
Lakowicz J.R., 2006, Principles of Fluorescence Spectroscopy, V3rd, P157, DOI DOI 10.1007/978-0-387-46312-4_5
[14]  
Lichtenberger LM, 2009, DRUG TODAY, V45, P877, DOI 1396674/dot.2009.45.12.1441075
[15]  
Lin JH, 1997, PHARMACOL REV, V49, P403
[16]   Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [J].
Loeliger, A. ;
Suthar, A. B. ;
Ripin, D. ;
Glaziou, P. ;
O'Brien, M. ;
Renaud-Thery, F. ;
Crowley, S. ;
Williams, B. ;
Ridzon, R. ;
Granich, R. ;
Gilks, C. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (01) :6-15
[17]   High-throughput microplate assay for the determination of drug partition coefficients [J].
Magalhaes, Luis M. ;
Nunes, Claudia ;
Lucio, Marlene ;
Segundo, Marcela A. ;
Reis, Salette ;
Lima, Jose L. F. C. .
NATURE PROTOCOLS, 2010, 5 (11) :1823-1830
[18]   Structural and calorimetrical studies of the effect of different aminoglycosides on DPPC liposomes [J].
Oszlanczi, Agnes ;
Bota, Attila ;
Czabai, Gabor ;
Klumpp, Erwin .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2009, 69 (01) :116-121
[19]  
Peetla C., 2009, MOL PHARM, V6, P8053
[20]   Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development [J].
Pignatello, R. ;
Musumeci, T. ;
Basile, L. ;
Carbone, C. ;
Puglisi, G. .
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2011, 3 (01) :4-14